Hui Cai

Corporate Officer/Principal at WUXI APPTEC CO., LTD.

Consumer Services

Health Technology

Profile

Hui Cai is currently the VP-Corporate Alliances & Communications at WuXi AppTec Co., Ltd.
Prior to this, Dr. Cai held the position of Vice President-Corporate Development at HUYA Bioscience International LLC and President at Inflexion BioPartners, Inc. Dr. Cai's education includes a doctorate from The Scripps Research Institute, undergraduate and graduate degrees from Peking University, and an MBA from the University of California San Diego.

Hui Cai active positions

Companies	Position	Start
WUXI APPTEC CO., LTD.	Corporate Officer/Principal	-

All active positions of Hui Cai

Former positions of Hui Cai

Companies	Position	End
Inflexion BioPartners, Inc.	President	-
HUYA Bioscience International LLC HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.	Corporate Officer/Principal	-

See the detail of Hui Cai's experience

Training of Hui Cai

The Scripps Research Institute	Doctorate Degree
Peking University	Graduate Degree
University of California San Diego	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hui Cai's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
WUXI APPTEC CO., LTD.	Health Technology

Private companies	2
HUYA Bioscience International LLC HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.	Health Technology
Inflexion BioPartners, Inc.